FIGURE 2.

Effect of incretin-based therapies (alogliptin and semaglutide) and doxorubicin (DOX) on the kidney index. Data are represented as mean ± SEM. * is significant compared to the control group at p <0.05. # is significant compared to the DOX group at p <0.05.